Vitamin D supplements did not prevent cancer or heart disease in a trial of 25,871 adults
Low vitamin D is linked to many diseases. When researchers tested supplements in a large randomised trial, the main results were disappointing.
Vitamin D is one of the most popular supplements in the world. Observational studies have linked low blood levels to heart disease, cancer, depression and early death. The question is whether taking it changes anything.
The VITamin D and OmegA-3 TriaL (VITAL), led by JoAnn Manson at Brigham and Women's Hospital and Harvard Medical School, set out to answer that. Its main results were published in the New England Journal of Medicine in 2019.
The trial
- 25,871 adults in the United States: men aged 50 and over and women aged 55 and over, with no history of cancer or cardiovascular disease.
- Participants were randomly assigned to 2,000 IU of vitamin D3 a day or a placebo, and separately to 1 g of omega-3 fish oil or a placebo.
- Median follow-up was 5.3 years.
What they found
- Vitamin D did not reduce the incidence of invasive cancer.
- It did not reduce major cardiovascular events (heart attack, stroke or cardiovascular death).
- It did not reduce death from any cause.
- No excess risk of high calcium levels or other side effects was found.
In a later analysis, the researchers reported that meta-analyses including VITAL suggested a reduction in cancer deaths, but not in cancer incidence or cardiovascular disease. The omega-3 arm of the trial also did not reduce the main cardiovascular or cancer outcomes.
So should you take it?
Vitamin D has established benefits for bone health, and deficiency is common in northern countries during winter. The VITAL results suggest that, for people who are not deficient, extra vitamin D is unlikely to prevent cancer or heart disease.
How to apply it
- If you live at northern latitudes and get little sun in winter, a modest daily dose (often 400 to 1,000 IU) is commonly recommended by health authorities during the darker months.
- People with darker skin, those who cover most of their skin or spend most of their time indoors have a higher risk of deficiency.
- If unsure, ask your doctor for a blood test rather than taking high doses.
- Do not rely on supplements in place of exercise, a good diet and not smoking.
A note on the evidence
Most VITAL participants had adequate vitamin D levels at the start, so the trial says less about people who are deficient.
Sources
- Manson JE et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 2019.
- Manson JE, Bassuk SS, Buring JE. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. Journal of Steroid Biochemistry and Molecular Biology, 2020.




